Director, HTA, Value & Evidence, Prostate Cancer
11/01/2024,
Pfizer
New York, NY
Director | Pharmaceutical/Bio-tech
Oncology Field Medical, Director Thoracic (non
11/01/2024,
Pfizer
Olympia, WA
Director | Pharmaceutical/Bio-tech
Director, HTA, Value & Evidence, Prostate Cancer
11/01/2024,
Pfizer
St. Louis, MO
Director | Pharmaceutical/Bio-tech
Oncology Field Medical, Director Thoracic (MD)
11/01/2024,
Pfizer
Olympia, WA
Director | Pharmaceutical/Bio-tech
Oncology Field Medical, Director Thoracic (MD)
11/01/2024,
Pfizer
Remote, OR 97458
Director | Pharmaceutical/Bio-tech
Director, HTA, Value & Evidence, Prostate Cancer
11/01/2024,
Pfizer
Lake Forest, IL
Director | Pharmaceutical/Bio-tech
Director, HTA, Value & Evidence, Prostate Cancer
11/01/2024,
Pfizer
New York, NY
Director | Pharmaceutical/Bio-tech
Oncology Field Medical, Director Thoracic (non
11/01/2024,
Pfizer
Boise, ID
Director | Pharmaceutical/Bio-tech
Oncology Field Medical, Director Thoracic (MD)
11/01/2024,
Pfizer
Helena, MT
Director | Pharmaceutical/Bio-tech
Director, HTA, Value & Evidence, Prostate Cancer
11/01/2024,
Pfizer
Bothell, WA
Director | Pharmaceutical/Bio-tech